ArticleJournal of clinical medicine2020

Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies.

Catalin Constantinescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.